Editorial Note: Olmesartan Potentiates the Anti-Angiogenic Effect of Sorafenib in Mice Bearing Ehrlich's Ascites Carcinoma: Role of Angiotensin (1-7).

Saved in:
Bibliographic Details
Main Author: PLOS ONE Editors
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2024-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0316407
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841555454189109248
author PLOS ONE Editors
author_facet PLOS ONE Editors
author_sort PLOS ONE Editors
collection DOAJ
format Article
id doaj-art-4cc22eef06f0421c906e47c63f192d85
institution Kabale University
issn 1932-6203
language English
publishDate 2024-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-4cc22eef06f0421c906e47c63f192d852025-01-08T05:32:54ZengPublic Library of Science (PLoS)PLoS ONE1932-62032024-01-011912e031640710.1371/journal.pone.0316407Editorial Note: Olmesartan Potentiates the Anti-Angiogenic Effect of Sorafenib in Mice Bearing Ehrlich's Ascites Carcinoma: Role of Angiotensin (1-7).PLOS ONE Editorshttps://doi.org/10.1371/journal.pone.0316407
spellingShingle PLOS ONE Editors
Editorial Note: Olmesartan Potentiates the Anti-Angiogenic Effect of Sorafenib in Mice Bearing Ehrlich's Ascites Carcinoma: Role of Angiotensin (1-7).
PLoS ONE
title Editorial Note: Olmesartan Potentiates the Anti-Angiogenic Effect of Sorafenib in Mice Bearing Ehrlich's Ascites Carcinoma: Role of Angiotensin (1-7).
title_full Editorial Note: Olmesartan Potentiates the Anti-Angiogenic Effect of Sorafenib in Mice Bearing Ehrlich's Ascites Carcinoma: Role of Angiotensin (1-7).
title_fullStr Editorial Note: Olmesartan Potentiates the Anti-Angiogenic Effect of Sorafenib in Mice Bearing Ehrlich's Ascites Carcinoma: Role of Angiotensin (1-7).
title_full_unstemmed Editorial Note: Olmesartan Potentiates the Anti-Angiogenic Effect of Sorafenib in Mice Bearing Ehrlich's Ascites Carcinoma: Role of Angiotensin (1-7).
title_short Editorial Note: Olmesartan Potentiates the Anti-Angiogenic Effect of Sorafenib in Mice Bearing Ehrlich's Ascites Carcinoma: Role of Angiotensin (1-7).
title_sort editorial note olmesartan potentiates the anti angiogenic effect of sorafenib in mice bearing ehrlich s ascites carcinoma role of angiotensin 1 7
url https://doi.org/10.1371/journal.pone.0316407
work_keys_str_mv AT plosoneeditors editorialnoteolmesartanpotentiatestheantiangiogeniceffectofsorafenibinmicebearingehrlichsascitescarcinomaroleofangiotensin17